Health committee, PHDCCI in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt of India organised the second series of Self Sufficiency in Medical Technology on ‘Innovation & Incentivisation of Indigenous MedTech Manufacturing’ on January 15 2021.

The Guest of Honour of the session was Dr S Eswara Reddy, Joint Drugs Controller General of India, CDSCO, complemented the MedTech industry for doing an excellent job in the last decade, yet accessibility needs to improve significantly. Dr Reddy said that the government provides many schemes to promote innovation and pooling of the R&D funds which are offered by the various ministries could significantly give an impetus to the medtech ecosystem.

The webinar was graced with the presence of Pradeep Multani, Sr Vice President, PHDCCI, Dr N Subramanian, Chair, Health Committee, PHDCCI & Director, Medical Services, Indraprastha Apollo Hospitals, Dr Sameer Gupta, Co-Chair, Health Committee, PHDCCI & Director, Cardiac Cath Lab, Metro Group of Hospitals and Prof (Dr) Harvinder Popli, Co-Chair, Health Committee, PHDCCI & Director, SPS, Delhi Pharmaceutical Sciences and Research University, Govt of NCT of Delhi.

Multani hailed the PLI and Promotion of Medical Devices Parks scheme and said that these initiatives have the potential to contribute significantly to achieving higher objectives of affordable healthcare in the country and globally on a sustained basis.

Dr Sharma said that we should not discriminate research by nature of institutions as government or private and we must have national R&D fund which does not discriminate between government and private institutions.

Dr Subramanian mentioned that the industry should have the approach to produce minimal invasive and preventive healthcare.

Dr Popli talked about standards and compliances in the manufacturing, lack of trained manpower & told to have right framework for the same.

The session was moderated by Vivek Seigell, Assistant Secretary General, PHDCCI.